Skip to main content

Intended for Healthcare Professionals

Johnson and Johnson logo graphic link
/en-US

HCP Global Navigation Ribbon

  • Home
  • About Us
      Back
    • About J&J MedTech
    • At-a-Glance
    • Careers
    • Investors
    • Our Companies
  • Our Stories
  • Our Impact
      Back
    • All Support Resources
    • HCP Education
    • Health System Customer Programs
    • My Health Can’t Wait
    • Sustainability
  • News
  • Contact
  • acclarent logo
  • biosense webster logo
  • cerenovus jjmdc logo
  • DePuy Synthes
  • Ethicon Logo
  • Mentor Logo

Intended for HCPs

Intended for Healthcare Professionals

Secondary nav block

biosense webster logo
  • Products
    • All Products
    • 3D Navigation
    • Therapeutic Catheters
    • Diagnostic Catheters
    • Ultrasound Solutions
    • Access Products
    • Generators
    • Data Solutions
  • Service
  • Clinical and Economic Research
    • Clinical and Economic Research Hub
    • ATTEST
    • PRECEPT
  • Resources
    • J&J Institute
    • Reimbursement
    • Education Grants
    • Electrophysiology Media Toolkit
    • Instructions For Use
    • Magnetic Resonance Imaging (MRI)
    • Medical Information Request (MIR)
    • California Compliance
  • News
  • About Us
    • Our Company
    • Contact Us
  • My Account
    • Login
    • Create an Account
  1. Home
  2. Therapeutic Catheters
  3. THERMOCOOL SMARTTOUCH® Catheter

THERMOCOOL SMARTTOUCH® Catheter

Deliver a measure of success to your cardiac arrhythmia patients with the THERMOCOOL SMARTTOUCH® Catheter. Greater catheter stability results in more consistent contact force, producing more uniform lesions. The SMART-AF Trial evaluated the safety and effectiveness of the THERMOCOOL SMARTTOUCH® Catheter in patients with drug-resistant paroxysmal atrial fibrillation. One-year results from the trial showed patients experienced an overall success rate of 74 percent.1 Importantly, a subanalysis from the trial demonstrated an 88 percent success rate when contact force was within an investigator-selected range greater than or equal to 85 percent of time.*

Contact Us
Instructions for Use
CARTO® THERMOCOOL SMARTTOUCH® Catheter
biosense webster logo

Features & Benefits

FB_Carto_Thermocool_Smartouch_Image
  • Provides consistent movement in response to contact force using precision spring
  • Sends accurate location reference signal via location sensor and transmitter coil
  • Promotes consistent lesion formation
  • Reduces ablation time2
  • Improves outcomes with more stable catheter-tissue contact force3
  • Force-sensing technology that provides real-time measurement of contact force between the catheter tip and the heart wall
  • Tip electrode serves to deliver RF current from the RF generator to the desired ablation site
  • A thermocouple temperature sensor is embedded in the tip electrode
  • High-torque shaft with a bi-directional deflectable tip section containing an array of electrodes

Product Resources

THERMOCOOL SMARTTOUCH® Catheter

Ordering
Number

Size

Curve

Tip
Electrode

Number
Of Electrodes

Spacing

Insertion
Length

D133601

8F

D

3.5 mm

6

1-6-2 mm

115 cm

D133602

8F

F

3.5 mm

6

1-6-2 mm

115 cm

D133603

8F

J

3.5 mm

6

1-6-2 mm

115 cm

 

Associated Cables

Catalog
Number

Connects

CR3434CT

Catheter to CARTO® 3 System PIU

 

Associated Tubing

Catalog
Number

Description

CFT001

CoolFlow® Pump Tubing (1 per pack)

SAT001

SMARTABLATE® System

 

THERMOCOOL SMARTTOUCH® Bi-Directional Catheter

Ordering
Number

Size

Curve

Tip
Electrode

Number
Of Electrodes

Spacing

Insertion
Length

D132701

8F

D-D

3.5 mm

6

1-6-2 mm

115 cm

D132702

8F

F-F

3.5 mm

6

1-6-2 mm

115 cm

D132703

8F

J-J

3.5 mm

6

1-6-2 mm

115 cm

D132704

8F

F-J

3.5 mm

6

1-6-2 mm

115 cm

D132705

8F

D-F

3.5 mm

6

1-6-2 mm

115 cm

 

Associated Cables

Catalog
Number

Connects

CR3434CT

Catheter to CARTO® 3 System PIU

 

Associated Tubing

Catalog
Number

Description

CFT001

CoolFlow® Pump Tubing (1 per pack)

References

1Natale A, Reddy VY, Monir G, et al. Paroxysmal AF catheter ablation with a contact force sensing catheter: results of the prospective, multicenter SMART AF trial. J Am Coll Cardiol 2014;64:647–56. *Success defined as freedom from any symptomatic atrial arrhythmia (atrial fibrillation, atrial flutter, atrial tachycardia) 12 months postprocedure when operator remained in the preset contact force range.The success rate improved to 81% (from 74%) when the investigator stayed within their preselected CF range =80% of the time (=85%: n=48; <85%: n=53). Further sub-analysis showed that when the contact force was within investigator-selected range =85% of time, success rate increased by 21% to 88% (=85%: n=32; <85%: n=73).

2Martinek M, Lemes C, et al. Clinical impact of an open-irrigated radiofrequency catheter with direct force measurement on atrial fibrillation ablation. Pacing Clin Electrophysiol. 2013;35(11):1312-1318.

3Kumar S, Morton JB, Lee J, et al. Prospective characterization of catheter-tissue contact force at different anatomic sites during antral pulmonary vein isolation. Circ Arrhythm Electrophysiol. 2012;5:1124-1129.

Available in bidirectional platform

105369-201014

Last Updated on 6/29/2020

This site is published by Biosense Webster, Inc. which is solely responsible for its contents.  It is intended for visitors from the United States.

biosense webster logo

         
  Twitter

 

LinkedIn

 

Facebook

 

 
Johnson and Johnson logo
Johnson & Johnson
  • Privacy Policy
  • Legal Notice
  • Do Not Sell My Personal Information
  • Contact Us
  • J&J Institute
  • Accessibility Statement
English (United States)

© Medical Device Business Services, Inc. 2021, 2022. All rights reserved.

This information is intended for use by customers, patients, and healthcare professionals in the United States only. We recognize that the Internet is a global communications medium; however, laws, regulatory requirements, and product information for medical products can vary from country to country. The product information included here may not be appropriate for use outside the United States, and the information from other sites you visit may not be appropriate for use in the United States.

You are about to leave jnjmedtech.com. By clicking to continue, you will be taken to a web site governed by their own Legal and Privacy Policies.

Yes, Continue to External Site No, Stay Here